(Forbes) – The virus was engineered by Dr. Matthias Gromeier, a molecular biologist at Duke who has been working on the treatment for the last 25 years. As Pelley explained, Gromeier removed part of the virus’ genetic material, which rendered it incapable of harming normal cells. That means it can only replicate in cancer cells, and in the process of doing so, it kills them while sparing healthy tissues. It’s a promising new approach in the burgeoning area of cancer immunotherapy.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.